急性冠状动脉综合征的优化管理 - Suppr

Suppr

超能文献

Optimal management of acute coronary syndromes.

作者信息

Hillis L David, Lange Richard A

出版信息

N Engl J Med. 2009 May 21;360(21):2237-40. doi: 10.1056/NEJMe0902632.

DOI:10.1056/NEJMe0902632

PMID:19458369

Abstract

摘要

相似文献

Optimal management of acute coronary syndromes.

N Engl J Med. 2009 May 21;360(21):2237-40. doi: 10.1056/NEJMe0902632.

Clinical policy: critical issues in the evaluation and management of adult patients with non-ST-segment elevation acute coronary syndromes.

Ann Emerg Med. 2006 Sep;48(3):270-301. doi: 10.1016/j.annemergmed.2006.07.005.

Optimizing antiplatelet therapy for the ACS patient: reacting to clinical trial data from the ISAR-REACT-2 studies.

Rev Cardiovasc Med. 2006;7 Suppl 4:S12-9.

Managing unstable angina in high-risk patients.

J Invasive Cardiol. 2002 Feb;14 Suppl A:31A-48A.

The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.

J Am Coll Cardiol. 2009 Aug 18;54(8):678-85. doi: 10.1016/j.jacc.2009.05.025.

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

N Engl J Med. 2001 Jun 21;344(25):1879-87. doi: 10.1056/NEJM200106213442501.

[Glycoprotein IIb/IIIa receptor antagonists for improving thrombolytic and interventional therapy in patients with acute myocardial infarct].

Dtsch Med Wochenschr. 2000 Oct 27;125(43):1297-300. doi: 10.1055/s-2000-7992.

Now, I am proud to be a Radialist.

Catheter Cardiovasc Interv. 2009 Sep 1;74(3):418-9. doi: 10.1002/ccd.22219.

Antiplatelet intervention in acute coronary syndrome.

Am J Ther. 2009 Sep-Oct;16(5):e29-40. doi: 10.1097/MJT.0b013e31804c7238.

[Blockers of platelet glycoprotein IIb/IIIa-receptors in the treatment of patients with acute coronary syndrome and during transcutaneous coronary interventions].

Ter Arkh. 2009;81(1):84-7.

引用本文的文献

Comparison of RISK-PCI, GRACE, TIMI risk scores for prediction of major adverse cardiac events in patients with acute coronary syndrome.

Croat Med J. 2017 Dec 31;58(6):406-415. doi: 10.3325/cmj.2017.58.406.

Antiplatelet therapy in acute coronary syndromes: focus on ticagrelor.

J Blood Med. 2010;1:197-219. doi: 10.2147/JBM.S9650. Epub 2010 Sep 1.

Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal.

Trials. 2010 Aug 12;11:85. doi: 10.1186/1745-6215-11-85.

Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention.

Vasc Health Risk Manag. 2009;5:677-91. doi: 10.2147/vhrm.s4828. Epub 2009 Aug 20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验